Heroin (diacetylmorphine)

Safety Summary

Regulatory Status

Sources

These citations are the ones recorded for the human adult context.

• US DEA: Heroin (Diacetylmorphine) — Schedule I Classification, No Accepted Medical Use, Fentanyl Contamination of Supply Chain, Naloxone Reversal, and Body Packer Toxicology (21 USC 812; 2022) REGULATORY · 2022
• US CDC: Opioid Overdose Surveillance — Heroin-Involved Deaths, NOWS Birth Prevalence, Fentanyl Displacement of Heroin Supply (2013–2023), and Naloxone Distribution Data (2023) REGULATORY · 2023
• identity database ECHA CHEM, Download all substances: REACH registrations (ECHA's own list of REACH-registered substances) REGULATORY · 2026
• OEHHA Proposition 65 List of Carcinogens or Reproductive Toxicants (CSV, list date 31-Jul-26) REGULATORY
• where to look DrugBank, as recorded by PubChem (Experimental Properties, CID 5462328; where-to-look, not a source of this value) DATABASE · 2026
• where to look Hazardous Substances Data Bank (HSDB), as recorded by PubChem (Experimental Properties, CID 5462328; where-to-look, not a source of this value) DATABASE · 2026
• EPA CompTox CTX API: predicted properties for DTXSID6046761 (Heroin (diacetylmorphine)) REFERENCE

Same data as the API response, which is open and needs no key. The full per-record source list is available to authenticated callers.